Stearoyl co-a desaturase 1 as a ccRCC therapeutic target: Death by stress

Clinical Cancer Research

Volumn 19, Issue 12, 2013, Pages 3111-3113

  Leung, Janet Y ^a   Kim, William Y ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 939572; ACYL COENZYME A DESATURASE 1; HYPOXIA INDUCIBLE FACTOR; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; OXYGENASE INHIBITOR; PAZOPANIB; SATURATED FATTY ACID; SUNITINIB; TEMSIROLIMUS; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; DRUG POTENTIATION; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; HUMAN; KIDNEY CARCINOMA; NONHUMAN; PRIORITY JOURNAL; UNFOLDED PROTEIN RESPONSE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; STEAROYL-COA DESATURASE;

EID: 84879491905     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-0800     Document Type: Article

References (10)

1. Roemeling von CA, Marlow LA, Wei JJ, Cooper SJ, Caulfield TR, Tan WW, et al. Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res 2013;19: 2368-80.
2. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer; 2007;7:763-77.
3. Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 2010;31:1509-15.
4. Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 2004;4:966-77.
5. Ricoult SJH, Manning BD. The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep 2013;14:242-51.
6. Kim WY, Kaelin WG. Role of VHLgene mutation inhuman cancer. J Clin Oncol 2004;22:4991-5004.
7. Kim J-W, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006;3: 177-85.
8. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006;3:187-97.
9. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996;271: 32529-37.
10. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2012;481:380-4.